Cargando...
The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer's Disease
BACKGROUND: Vascular risk factors (VRF) may influence response to rivastigmine in Alzheimer's disease (AD). METHODS: AD patients who participated in a randomized, double-blind, placebo-controlled trial of rivastigmine patch and capsule treatment were stratified by baseline VRF status. Treatment...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3199893/ https://ncbi.nlm.nih.gov/pubmed/22163241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000328745 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|